MedPath

Effect of Unani Medicine Qurs-e-Habis in Kasrat e tams (Heavy Menstrual Bleeding)

Phase 2
Conditions
Health Condition 1: N920- Excessive and frequent menstruation with regular cycleHealth Condition 2: null- Kasrat e tams (Heavy Menstrual Bleding)
Registration Number
CTRI/2018/08/015448
Lead Sponsor
Central Council For Research In Unani Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Non- gravid - non menopausal females with age 19-45years

2. Patients with menorrhagia as indicated by :

(i) Excessive Menstrual loss > 80ml/cycle as calculated by menstrual pictogram (attached as annexure)

(ii) Menstrual cycle greater than 6 days

Exclusion Criteria

1. Heavy Menstrual Bleeding with structural or histological abnormality, with symptoms such as intermenstrual or post-coital bleeding, pelvic pain and/or pressure symptoms

2. Patients presenting with Heavy Menstrual Bleeding since menarche

3. Patients with a personal or family history suggesting acoagulation disorder

4. Patients using Intrauterine Contraceptive Devices

5. Patients with illness requiring long term treatment e.g. Hypertension, TB etc

6. Patients with Post-menopausal bleeding,

7. Patients with Heavy Menstrual Bleeding taking Hormone Replacement Therapy

8. Conditions where Heavy Menstrual Bleeding is not the main presenting menstrual symptom eg endometriosis

9. Pregnant and lactating females

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
improvement in the sign and symptoms of Kasrat e tams (Heavy Menstrual Bleeding)Timepoint: Twelve Weeks
Secondary Outcome Measures
NameTimeMethod
Hematological and biochemical assessments for safetyTimepoint: 12 weeks
© Copyright 2025. All Rights Reserved by MedPath